Publication | Closed Access

A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation

Medicinal ChemistryChemoprevention StrategyMedicineHybrid Anticancer AgentsAnti-proliferative EvaluationNew ClassTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryNatural Product Synthesis